Literature DB >> 8168932

Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media.

K Suzuki1, L O Bakaletz.   

Abstract

We recently reported the development of a chinchilla model of experimental otitis media (OM) that uses a pediatric clinical isolate of adenovirus type 1 (4) and in which an active infection with the wild-type strain was demonstrated. To expand upon these findings, this study was designed to determine whether we could demonstrate adenovirus infection-induced predisposition to bacterial OM in the chinchilla, as has been shown in human epidemiological studies (D. A. Clements, F. W. Henderson, and E. C. Neebe, p. 27-29, in D. J. Lim, C. D. Bluestone, J. O. Klein, D. J. Nelson, and P. L. Ogra, ed., Proceedings of the Fifth International Symposium on Recent Advances in Otitis Media, 1993; F. W. Henderson, A. M. Collier, M. A. Sanyai, et al., N. Engl. J. Med. 306:1377-1383, 1982). In addition, we were interested in determining whether altering the order of pathogen acquisition would further affect the outcome of disease incidence and severity. Toward this end, cohorts of chinchillas were inoculated intranasally with a strain of nontypeable Haemophilus influenzae (NTHi) (86-028NP) which colonizes the chinchilla nasopharynx but does not consistently induce culture-positive OM when inoculated intranasally (L. O. Bakaletz, T. M. Hoepf, D. J. Lim, and B. Tallan, Abstr. 90th Annu. Meet. Am. Soc. Microbiol. 1990, abstr. B-66, p. 37, 1990), adenovirus type 1 and then inoculated 7 days later with NTHi, NTHi and then inoculated 7 days later with adenovirus type 1, or both pathogens concurrently. All cohorts were observed over a 35-day period and assessed for incidence and severity of OM by several methodologies. The data collectively indicated that all animals receiving both pathogens developed OM of greater severity than those receiving only a single agent. Adenovirus inoculation followed 7 days later by NTHi inoculation was the order of pathogen acquisition which induced the most prolonged presence of NTHi in both the nasopharynx and the middle ear, the most severe tympanic membrane inflammation overall, and the most significant damage to and altered function of both middle ear and eustachian tube mucosae.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168932      PMCID: PMC186390          DOI: 10.1128/iai.62.5.1710-1718.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment.

Authors:  J A Koziol; D A Maxwell; M Fukushima; M E Colmerauer; Y H Pilch
Journal:  Biometrics       Date:  1981-06       Impact factor: 2.571

2.  Isolation of viruses and mycoplasmas from middle ear effusions: a review.

Authors:  J O Klein; D W Teele
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Mar-Apr       Impact factor: 1.547

3.  Modeling adenovirus type 1-induced otitis media in the chinchilla: effect on ciliary activity and fluid transport function of eustachian tube mucosal epithelium.

Authors:  L O Bakaletz; R L Daniels; D J Lim
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

4.  A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion.

Authors:  F W Henderson; A M Collier; M A Sanyal; J M Watkins; D L Fairclough; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

5.  Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas.

Authors:  G S Giebink; P F Wright
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

6.  Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.

Authors:  G S Giebink; I K Berzins; S C Marker; G Schiffman
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

7.  Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide.

Authors:  G S Giebink; I K Berzins; G Schiffman; P G Quie
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

8.  Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media.

Authors:  J S Abramson; G S Giebink; P G Quie
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Tympanometric configurations and middle ear findings in experimental otitis media.

Authors:  G S Giebink; K A Heller; E R Harford
Journal:  Ann Otol Rhinol Laryngol       Date:  1982 Jan-Feb       Impact factor: 1.547

10.  Experimental otitis media in chinchillas.

Authors:  D M Lewis; J L Schram; S J Meadema; D J Lim
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1980 May-Jun
View more
  74 in total

1.  Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and com operons.

Authors:  Michael D Carruthers; Erin N Tracy; Amanda C Dickson; Kara B Ganser; Robert S Munson; Lauren O Bakaletz
Journal:  J Bacteriol       Date:  2012-02-10       Impact factor: 3.490

Review 2.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

3.  A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.

Authors:  Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

4.  The OxyR regulon in nontypeable Haemophilus influenzae.

Authors:  Alistair Harrison; William C Ray; Beth D Baker; David W Armbruster; Lauren O Bakaletz; Robert S Munson
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

5.  Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.

Authors:  Marjolein M P Oerlemans; Sam J Moons; Jurriaan J A Heming; Thomas J Boltje; Marien I de Jonge; Jeroen D Langereis
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

6.  Development of a chinchilla model to allow direct, continuous, biophotonic imaging of bioluminescent nontypeable Haemophilus influenzae during experimental otitis media.

Authors:  Laura A Novotny; Kevin M Mason; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media.

Authors:  Kevin M Mason; Robert S Munson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20.

Authors:  Alistair Harrison; David W Dyer; Allison Gillaspy; William C Ray; Rachna Mungur; Matthew B Carson; Huachun Zhong; Jenny Gipson; Mandy Gipson; Linda S Johnson; Lisa Lewis; Lauren O Bakaletz; Robert S Munson
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

9.  Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae.

Authors:  W Edward Swords; Miranda L Moore; Luciana Godzicki; Gail Bukofzer; Michael J Mitten; Jessica VonCannon
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.